The Briefing: Okta To Buy Auth0 for $6.5B, Volocopter Lands $240M, And More

Identity management has been one of the areas of security many experts thought would see increased interest as more and more services move online and companies and employers need to verify users. The latest round, backed by a long list of new and existing investors, brings total funding to date for the 10-year-old company to 322 million euros. Clari intends to use the proceeds of the investment round to accelerate product development, expand ecosystem partnerships and drive global expansion. The funding will advance its pre-clinical pipeline of products designed to resist host rejection, enhance cell persistence and allow repeat dosing to provide durable responses in patients. Meanwhile, atai Life Sciences, a New York-based clinical-stage biopharmaceutical company, secured $157 million in Series D financing led by existing investors Apeiron Investment Group and Thiel Capital.